These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24272611)

  • 1. Pharmacokinetics of two prototype nitroxide spin labels for contrast enhancement in magnetic resonance imaging.
    Couet WR; Eriksson UG; Brasch RC; Tozer TN
    Pharm Res; 1985 Mar; 2(2):69-72. PubMed ID: 24272611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics in the rat and the dog of a nonionic nitroxide contrast agent for magnetic resonance imaging.
    Eriksson UG; Schuhmann G; Brasch RC; Tozer TN
    J Pharm Sci; 1988 Feb; 77(2):97-103. PubMed ID: 2834531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolic fate of two nitroxides potentially useful as contrast agents for magnetic resonance imaging.
    Couet WR; Eriksson UG; Tozer TN; Tuck LD; Wesbey GE; Nitecki D; Brasch RC
    Pharm Res; 1984 Sep; 1(5):203-9. PubMed ID: 24277329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate in the dog of the nitroxide moiety in a compound with potential utility as a contrast agent in MRI.
    Eriksson UG; Ogan MD; Peng CT; Brasch RC; Tozer TN
    Magn Reson Med; 1987 Jul; 5(1):73-7. PubMed ID: 3657496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected rapid aerobic transformation of 2,2,6,6-tetraethyl-4-oxo(piperidin-1-yloxyl) radical by cytochrome P450 in the presence of NADPH: Evidence against a simple reduction of the nitroxide moiety to the hydroxylamine.
    Babić N; Orio M; Peyrot F
    Free Radic Biol Med; 2020 Aug; 156():144-156. PubMed ID: 32561320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of superoxide-induced exchange among nitroxide antioxidants and their oxidized and reduced forms.
    Zhang R; Goldstein S; Samuni A
    Free Radic Biol Med; 1999 May; 26(9-10):1245-52. PubMed ID: 10381196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism in rat liver microsomes of the nitroxide spin probe tempol.
    Iannone A; Bini A; Swartz HM; Tomasi A; Vannini V
    Biochem Pharmacol; 1989 Aug; 38(16):2581-6. PubMed ID: 2764982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals.
    Brasch RC; London DA; Wesbey GE; Tozer TN; Nitecki DE; Williams RD; Doemeny J; Tuck LD; Lallemand DP
    Radiology; 1983 Jun; 147(3):773-9. PubMed ID: 6844613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of ciprofloxacin following intravenous administration in dogs.
    Abadía AR; Aramayona JJ; Muñoz MJ; Pla Delfina JM; Saez MP; Bregante MA
    J Vet Pharmacol Ther; 1994 Oct; 17(5):384-8. PubMed ID: 7853464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo proton electron double resonance imaging of the distribution and clearance of nitroxide radicals in mice.
    Li H; He G; Deng Y; Kuppusamy P; Zweier JL
    Magn Reson Med; 2006 Mar; 55(3):669-75. PubMed ID: 16463344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbate-induced cancellation of nitroxide contrast media enhancement of MR images.
    Wikstrom MG; White DL; Moseley ME; Dupon JW; Brasch RC
    Invest Radiol; 1989 Sep; 24(9):692-6. PubMed ID: 2807822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous 280 MHz EPR imaging of rat organs during nitroxide free radical clearance.
    Alecci M; Ferrari M; Quaresima V; Sotgiu A; Ursini CL
    Biophys J; 1994 Sep; 67(3):1274-9. PubMed ID: 7811942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal administration of nitroxides as potential contrast agents for MR imaging.
    Rosen GM; Griffeth LK; Brown MA; Drayer BP
    Radiology; 1987 Apr; 163(1):239-43. PubMed ID: 3823443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroxides as cancer imaging agents.
    Davis RM; Mitchell JB; Krishna MC
    Anticancer Agents Med Chem; 2011 May; 11(4):347-58. PubMed ID: 21434855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The excretion mechanism of the spin label proxyl carboxylic acid (PCA) from the rat monitored by X-band ESR and PEDRI.
    Seimenis I; Foster MA; Lurie DJ; Hutchison JM; Whiting PH; Payne S
    Magn Reson Med; 1997 Apr; 37(4):552-8. PubMed ID: 9094077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exchange and shuttling of electrons by nitroxide spin labels.
    Nettleton DO; Morse PD; Swartz HM
    Arch Biochem Biophys; 1989 Jun; 271(2):414-23. PubMed ID: 2729999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.